Catherina Lueck1,2, Michael Stadler1, Christian Koenecke1, Marius M Hoeper3, Elke Dammann1, Andrea Schneider4, Jan T Kielstein5, Arnold Ganser1, Matthias Eder1, Gernot Beutel6,7. 1. Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. 2. Intensive Care in Hematologic and Oncologic Patients (iCHOP), Hannover, Germany. 3. Interdisciplinary Internal Intensive Care Unit, Department for Respiratory Diseases and German Centre of Lung Research (DZL), Hannover Medical School, Hannover, Germany. 4. Interdisciplinary Internal Intensive Care Unit, Department for Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany. 5. Interdisciplinary Internal Intensive Care Unit, Department for Nephrology and Hypertension, Hannover Medical School, Braunschweig, Germany. 6. Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. beutel.gernot@mh-hannover.de. 7. Intensive Care in Hematologic and Oncologic Patients (iCHOP), Hannover, Germany. beutel.gernot@mh-hannover.de.
Abstract
PURPOSE: Intensive care unit (ICU) admission of allogeneic hematopoietic stem cell transplant (HSCT) recipients is associated with relatively poor outcome. Since longitudinal data on this topic remains scarce, we analyzed reasons for ICU admission as well as short- and long-term outcome of critically ill HSCT recipients. METHODS: A total of 942 consecutive adult patients were transplanted at Hannover Medical School from 2000 to 2013. Of those, 330 patients were at least admitted once to the ICU and included in this retrospective study. To analyze time-dependent improvements, we separately compared patient characteristics as well as reasons and outcome of ICU admission for the periods 2000-2006 and 2007-2013. RESULTS: The main reasons for ICU admission were acute respiratory failure (ARF) in 35%, severe sepsis/septic shock in 23%, and cardiac problems in 18%. ICU admission was clearly associated with shortened survival (p < 0.001), but survival of ICU patients after hospital discharge reached 44% up to 5 years and was comparable to that of non-ICU HSCT patients. When ICU admission periods were compared, patients were older (48 vs. 52 years; p < 0.005) and the percentage of ARF as leading cause for ICU admission decreased from 43% in the first to 30% in the second period. Over time ICU and hospital survival improved from 44 to 60% (p < 0.01) and from 26 to 43% (p < 0.01), respectively. The 1- and 3-year survival rate after ICU admission increased significantly from 14 to 32% and from 11 to 23% (p < 0.01). CONCLUSIONS: Besides ARF and septic shock, cardiac events were especially a major reason for ICU admission. Both short- and long-term survival of critically ill HSCT patients has improved significantly in recent years, and survival of HSCT recipients discharged from hospital is not significantly affected by a former ICU stay.
PURPOSE: Intensive care unit (ICU) admission of allogeneic hematopoietic stem cell transplant (HSCT) recipients is associated with relatively poor outcome. Since longitudinal data on this topic remains scarce, we analyzed reasons for ICU admission as well as short- and long-term outcome of critically ill HSCT recipients. METHODS: A total of 942 consecutive adult patients were transplanted at Hannover Medical School from 2000 to 2013. Of those, 330 patients were at least admitted once to the ICU and included in this retrospective study. To analyze time-dependent improvements, we separately compared patient characteristics as well as reasons and outcome of ICU admission for the periods 2000-2006 and 2007-2013. RESULTS: The main reasons for ICU admission were acute respiratory failure (ARF) in 35%, severe sepsis/septic shock in 23%, and cardiac problems in 18%. ICU admission was clearly associated with shortened survival (p < 0.001), but survival of ICU patients after hospital discharge reached 44% up to 5 years and was comparable to that of non-ICU HSCT patients. When ICU admission periods were compared, patients were older (48 vs. 52 years; p < 0.005) and the percentage of ARF as leading cause for ICU admission decreased from 43% in the first to 30% in the second period. Over time ICU and hospital survival improved from 44 to 60% (p < 0.01) and from 26 to 43% (p < 0.01), respectively. The 1- and 3-year survival rate after ICU admission increased significantly from 14 to 32% and from 11 to 23% (p < 0.01). CONCLUSIONS: Besides ARF and septic shock, cardiac events were especially a major reason for ICU admission. Both short- and long-term survival of critically ill HSCT patients has improved significantly in recent years, and survival of HSCT recipients discharged from hospital is not significantly affected by a former ICU stay.
Authors: E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner Journal: N Engl J Med Date: 1975-04-24 Impact factor: 91.245
Authors: Damon C Scales; Deva Thiruchelvam; Alexander Kiss; William J Sibbald; Donald A Redelmeier Journal: Crit Care Date: 2008-06-11 Impact factor: 9.097
Authors: William M Townsend; Ailsa Holroyd; Rachel Pearce; Stephen Mackinnon; Prakesh Naik; Anthony H Goldstone; David C Linch; Karl S Peggs; Kirsty J Thomson; Mervyn Singer; David C J Howell; Emma C Morris Journal: Br J Haematol Date: 2013-03-18 Impact factor: 6.998
Authors: Jorge Garcia Borrega; Jan-Michel Heger; Matthias Kochanek; Dennis A Eichenauer; Philipp Koehler; Udo Holtick; Michael Hallek; Christof Scheid; Boris Böll; Alexander Shimabukuro-Vornhagen Journal: Ann Hematol Date: 2021-10-20 Impact factor: 3.673
Authors: Christian S Michel; Daniel Teschner; Irene Schmidtmann; Matthias Theobald; Beate Hauptrock; Eva M Wagner-Drouet; Markus P Radsak Journal: Sci Rep Date: 2019-12-27 Impact factor: 4.379
Authors: Philipp Wohlfarth; Peter Schellongowski; Thomas Staudinger; Werner Rabitsch; Alexander Hermann; Nina Buchtele; Amin T Turki; Asterios Tzalavras; Tobias Liebregts Journal: Artif Organs Date: 2021-05-04 Impact factor: 3.094